Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

News

March 21, 2017 – Our skin is covered in a web of billions of tiny organisms including bacteria, viruses and fungi. This web is called the skin microbiome and when healthy, helps our bodies function properly inside and out. Researchers have long known that people with atopic dermatitis (AD) have different skin biology than those […]

Read More


March 21, 2017 – Earlier this month, Republican leaders in the House of Representatives introduced the American Health Care Act (AHCA) to replace the Affordable Health Care Act (ACA) passed in March 2010. The ACA, also known as Obamacare, has several key components that protects access to health care for people with pre-existing conditions and/or chronic […]

Read More


Each year, thousands of doctors, scientists, students, industry and patient advocacy groups like National Eczema Association, gather to hear the latest research and standards of medical care in dermatology at the American Academy of Dermatology (AAD) Annual Meeting. Atopic dermatitis is a hot field of study. Here’s some highlights from this year’s AAD meeting. Biologic […]

Read More


February 21, 2017 — There are dozens of new drugs in development for atopic dermatitis (AD). Late last year, the Food and Drug Administration (FDA) approved the non-steroidal topical treatment, Eucrisa for mild to moderate atopic dermatitis. This March, the FDA is expected to approve dupilumab, the first biologic drug for adults with moderate to […]

Read More


Pain and poor sleep – two symptoms common to people with atopic dermatitis. When these symptoms spin out of control, every part of one’s life is impacted. To find out more about why and how pain and sleep problems affect people with atopic dermatitis, the National Eczema Association funded three studies in these areas as […]

Read More


January 17, 2017 — Biologic drugs have been making headlines as potentially promising new therapies for treating atopic dermatitis (AD). Several have shown positive results in clinical trials and one, dupilumab, is being reviewed for approval by the Food and Drug Administration (FDA) and is expected to come to market in 2017. Biologic medications are […]

Read More


January 17, 2017 — For the first time, ever, the Institute for Clinical and Economic Review (ICER) has begun a process to review the clinical effectiveness and value of two new treatments for atopic dermatitis (AD). ICER is an independent, nonprofit organization that evaluates treatments for serious diseases such as cancer, multiple sclerosis and psoriasis, […]

Read More


January 9. 2017 — Last week, a panel of experts sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) released new guidelines for reducing the risk of peanut allergies in children. This panel, which included National Eczema Association, recommended giving children 6 months and younger peanut-containing foods under the direction of a pediatrician or […]

Read More


By Christopher Logas and Peter A. Lio, MD We share a lot with our beloved canines: our home, our bed and sometimes, even our dinner. But did you know that humans share something else with dogs? A diagnosis of atopic dermatitis (AD). Dogs with canine atopic dermatitis (CAD) have many of the same symptoms as […]

Read More


What is atopic dermatitis (AD)? AD is a severe form of eczema, which is an umbrella term used to describe a group of conditions that result in itchy, red, and irritated skin. It is a chronic, inflammatory disease that results in red, itchy patches on the skin that can crack and weep. AD falls into […]

Read More